PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas

Anat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, Hong Zhou, Jingying Xu, Tom B. Davidson, Mathew Schur, Floyd H. Gilles, Lingyun Ji, Jemily Malvar, Gregory M. Shackleford, Ashley S. Margol, Mark D. Krieger, Alexander R. Judkins, David T.W. Jones, Stefan M. Pfister, Marcel Kool, Richard Sposto, Shahab Asgharazadeh

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

Purpose: We present here the first report of PID1 (Phosphotyrosine Interaction Domain containing 1; NYGGF4) in cancer. PID1 was identified in 2006 as a gene that modulates insulin signaling and mitochondrial function in adipocytes and muscle cells. Experimental Design and Results: Using four independent medulloblastoma datasets, we show that mean PID1 mRNA levels were lower in unfavorable medulloblastomas (groups 3 and 4, and anaplastic histology) compared with favorable medulloblastomas (SHH and WNT groups, and desmoplastic/nodular histology) and with fetal cerebellum. In two large independent glioma datasets, PID1 mRNA was lower in glioblastomas (GBM), the most malignant gliomas, compared with other astrocytomas, oligodendrogliomas and nontumor brains. Neural and proneural GBM subtypes had higher PID1 mRNA compared with classical and mesenchymal GBM. Importantly, overall survival and radiation-free progression-free survival were longer in medulloblastoma patients whose tumors had higher PID1 mRNA (univariate and multivariate analyses). Higher PID1mRNAalso correlated with longer overall survival in patients with glioma and GBM. In cell culture, overexpression of PID1 inhibited colony formation in medulloblastoma, atypical teratoid rhabdoid tumor (ATRT), and GBM cell lines. Increasing PID1 also increased cell death and apoptosis, inhibited proliferation, induced mitochondrial depolaization, and decreased serum-mediated phosphorylation of AKT and ERK in medulloblastoma, ATRT, and/orGBMcell lines, whereas siRNA to PID1 diminished mitochondrial depolarization. Conclusions: These data are the first to link PID1 to cancer and suggest that PID1 may have a tumor inhibitory function in these pediatric and adult brain tumors.

Original languageEnglish
Pages (from-to)827-836
Number of pages10
JournalClinical Cancer Research
Volume20
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas'. Together they form a unique fingerprint.

Cite this